AG01DNTL

943540-75-8 | 6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline

AG01DNTL

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	943540-75-8
Catalog Number	AG01DNTL(AGN-PC-080TYA)
Chemical Name	6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline
IUPAC Name	6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline
InChI	InChI=1S/C19H13F2N7/c1-27-11-13(10-23-27)16-6-7-17-24-25-18(28(17)26-16)19(20,21)14-4-5-15-12(9-14)3-2-8-22-15/h2-11H,1H3
InChI Key	JRWCBEOAFGHNNU-UHFFFAOYSA-N
MDL Number	MFCD11977274
Molecular Formula	C19H13F2N7
Molecular Weight	377.3502
SMILES	FC(C=1C=C2C=CC=NC2=CC1)(C1=NN=C2N1N=C(C=C2)C=2C=NN(C2)C)F
UNII	15UDG410PN
Synonyms	JNJ-38877605, JNJ38877605, JNJ-38877605, 943540-75-8, JNJ38877605, UNII-15UDG410PN, 6-(difluoro(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)quinoline, JNJ 38877605, 15UDG410PN, 6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline, 6-(Difluoro(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]-triazolo[4,3-b]pyridazin-3-yl)methyl)quinoline, C19H13F2N7, 6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline, 6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline, Quinoline, 6-(difluoro(6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)methyl)-, JRWCBEOAFGHNNU-UHFFFAOYSA-N, Quinoline, 6-[difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-, PubChem22454, cc-51, MLS006010960, SCHEMBL182199, J&J Ex-61, CHEMBL2133806, CHEBI:91417, DTXSID20677253, QCR-226, SYN1047, BDBM163243, HMS3244G09, HMS3244G10, HMS3244H09, HMS3654M04, AOB87321, BCP01812, EX-A2081, KS-00001DU4, ABP000134, RS0066, s1114, ZINC43170515, AKOS015896605, BCP9000804, DB13113, SB16606, NCGC00263189-01, NCGC00263189-06, AC-27418, AK320732, AN-16830, AS-16207, BC659966, HY-50683, SC-48063, SMR004702764, AB0008180, DB-000659, FT-0737555, SW220206-1, X7476, A19401, W-5504, 540D758, JNJ-38877605,JNJ38877605, JNJ-38877605/JNJ38877605, I06-2284, J-518058, BRD-K02123250-001-01-8, US9062045, Comparator No. 1 (JNJ-38877605), JNJ-38877605, JNJ 38877605, 943540-75-8, 1072116-03-0, 6-(Difluoro-[6-(1methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]-methyl)-quinoline, 6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[3,4-f]pyridazin-3-yl]methyl]quinoline, 6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-quinoline, 6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]-triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline, 6-{difluoro[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline, D0YT8P, J&JEx-61, CS-0031, A5092, A10493, C-met inhibitor (solid tumors), ORD/J&J PRD, C-met inhibitor, Ortho Biotech Oncology Research & Development,

Complexity	564
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	377.12g/mol
Formal Charge	0
Heavy Atom Count	28
Hydrogen Bond Acceptor Count	7
Hydrogen Bond Donor Count	0
Isotope Atom Count	0
Molecular Weight	377.359g/mol
Monoisotopic Mass	377.12g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	73.8A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	2.1

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	\N
Hazard statements	H317-H319
Packing Group	\N
Precautionary statements	P280-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number